McClung, M. R.
Bolognese, M. A.
Brown, J. P.
Reginster, J.-Y.
Langdahl, B. L.
Maddox, J.
Shi, Y.
Rojeski, M.
Meisner, P. D.
Grauer, A.
Funding for this research was provided by:
Amgen Inc. (Not applicable)
UCB Pharma (Not applicable)
Astellas (Not applicable)
Article History
Received: 11 June 2019
Accepted: 8 June 2020
First Online: 4 July 2020
Compliance with ethical standards
:
: MRM has received consulting fees and honoraria from Amgen and consulting fees from Myovant. MAB has received contract fees from and has been a speaker for Amgen. JPB has received research funding from Amgen, Eli Lilly, Mereo Biopharma, Radius Health, and Servier; has received consulting fees from Amgen, Eli Lilly, Orimed, and Servier; and has received lecture fees from Amgen and Eli Lilly. J-YR has received research funding from IBSA-Genevrier, Mylan, CNIEL, and Radius Health; has received lecture fees from IBSA-Genevrier, Mylan, CNIEL, and Dairy Research Council; and has received consulting fees from or participated in paid advisory boards for IBSA-Genevrier, Mylan, Radius Health, and Pierre Fabre. BLL has received research funding from Amgen and Novo Nordisk; has received consulting fees from Amgen, Eli Lilly, and UCB; and has received lecture fees from Amgen, Eli Lilly, and UCB. JM, YS, and MR are employees of and hold stock in Amgen. PDM is an employee of and holds stock in UCB Pharma. AG was an employee of Amgen at the time of the study and holds stock in Amgen.
: Qualified researchers may request data from Amgen clinical studies. Complete details are available at ExternalRef removed.